-

12:58:18 AM

LIVE Real Time TRXC Stock Market News

TRXC - TransEnterix Inc

03/05/21 6:55 AM

NYSE : ASXC, TRXC

Asensus Surgical Announces Finalization of Name and Ticker Symbol Change

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM), today announced the formal completion of its previously announced name and

RHEA-AI

neutral

03/04/21 6:55 AM

NYSE : TRXC

Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM), announced today that it plans to release fourth quarter and fiscal year 2020

RHEA-AI

neutral

03/03/21 6:55 AM

NYSE : TRXC

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM), today announced the Company has received an additional FDA clearance for the

RHEA-AI

neutral

03/01/21 6:55 AM

NYSE : TRXC

Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and

RHEA-AI

neutral

02/23/21 10:53 AM

NYSE : TRXC

TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc. The name change reflects the company's

RHEA-AI

very positive

02/18/21 8:45 AM

NYSE : TRXC

TransEnterix Announces New Training Center in EU

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical

RHEA-AI

neutral

02/10/21 6:55 AM

NYSE : TRXC

TransEnterix to Host Virtual Investor Day on February 23, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will host a virtual Investor Day on February 23, 2021, beginning at 11:00am Eastern Time."We are

RHEA-AI

neutral

02/01/21 4:05 PM

NYSE : TRXC

TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock. Including the full

RHEA-AI

neutral

01/26/21 10:57 PM

NYSE : TRXC

TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million

TransEnterix, Inc. (NYSE American: TRXC) ("TransEnterix" or the "Company"), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of

RHEA-AI

neutral

01/26/21 4:58 PM

NYSE : TRXC

TransEnterix Announces $25.0 Million Bought Deal Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC) ("TransEnterix" or the "Company"), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into an underwriting agreement with H.C. Wainwright &

RHEA-AI

neutral